Effect of oral antiseptics in reducing SARS-CoV-2 infectivity: evidence from a randomized double-blind clinical trial

References

• Worldometer. Coronavirus Cases. 2022; [cited May 27 2022]. Available from: https://www.worldometers.info/coronavirus/.
   Google Scholar
• Whitworth J. COVID-19: a fast evolving pandemic. Trans R Soc Trop Med Hyg. 2020;114(4):241–248.
   PubMed Web of Science ®Google Scholar
• Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–523.
   PubMed Web of Science ®Google Scholar
• To KK, Tsang OT, Yip CC, et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis. 2020;71(15):841–843.
   PubMed Web of Science ®Google Scholar
• Biber A, Lev D, Mandelboim M, et al. The role of mouthwash sampling in SARS-CoV-2 diagnosis. Eur J Clin Microbiol Infect Dis. 2021;40(10):2199–2206.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention – CDC. (2020). Guidance for dental settings: interim infection prevention and control guidance for dental settings during the coronavirus disease 2019 (COVID-19) pandemic; [Cited 2022 Jan 18]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/dental-settings.html.
   Google Scholar
• Mateos-Moreno MV, Mira A, Ausina-Marquez V, et al. Oral antiseptics against coronavirus: in-vitro and clinical evidence. J Hosp Infect. 2021;113:30–43.
   PubMed Web of Science ®Google Scholar
• Xu C, Wang A, Hoskin ER, et al. Differential effects of antiseptic mouth rinses on SARS-CoV-2 infectivity in vitro. Pathogens. 2021 Mar 1;10(3):272.
   PubMed Web of Science ®Google Scholar
• Munoz-Basagoiti J, Perez-Zsolt D, Leon R, et al. Mouthwashes with CPC reduce the infectivity of SARS-CoV-2 variants in vitro. J Dent Res. 2021;100(11):1265–1272.
   PubMed Web of Science ®Google Scholar
• Koch-Heier J, Hoffmann H, Schindler M, et al. Inactivation of SARS-CoV-2 through treatment with the mouth rinsing solutions ViruProX® and BacterX® Pro. Microorganisms. 2021 Mar 3;9(3):521.
   PubMed Web of Science ®Google Scholar
• Davies K, Buczkowski H, Welch SR, et al. Effective in vitro inactivation of SARS-CoV-2 by commercially available mouthwashes. J Gen Virol. 2021 Apr;102(4):001578.
   PubMed Web of Science ®Google Scholar
• Tadakamadla J, Boccalari E, Rathore V, et al. In vitro studies evaluating the efficacy of mouth rinses on sars-Cov-2: A systematic review. J Infect Public Health. 2021;14(9):1179–1185.
   PubMed Web of Science ®Google Scholar
• Komine A, Yamaguchi E, Okamoto N, et al. Virucidal activity of oral care products against SARS-CoV-2 in vitro. J Oral Maxillofac Surg Med Pathol. 2021;33(4):475–477.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wu Y, Wang Q, et al. Virucidal effect of povidone-iodine against SARS-CoV-2 in vitro. J Int Med Res. 2021 Dec;49(12):3000605211063695.
   Web of Science ®Google Scholar
• Seneviratne CJ, Balan P, Ko KKK, et al. Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore. Infection. 2021;49(2):305–311.
   PubMed Web of Science ®Google Scholar
• Martínez Lamas L, Diz Dios P, Pérez Rodríguez MT, et al. Is povidone iodine mouthwash effective against SARS-CoV-2? First in vivo tests. Oral Dis. 2022 Apr;28(Suppl 1):908–911.
   PubMed Web of Science ®Google Scholar
• Gottsauner MJ, Michaelides I, Schmidt B, et al. A prospective clinical pilot study on the effects of a hydrogen peroxide mouthrinse on the intraoral viral load of SARS-CoV-2. Clin Oral Investig. 2020;24(10):3707–3713.
   PubMed Web of Science ®Google Scholar
• Yoon JG, Yoon J, Song JY, et al. Clinical significance of a high SARS-CoV-2 viral load in the saliva. J Korean Med Sci. 2020 May 25;35(20):e195.
   PubMed Web of Science ®Google Scholar
• Ferrer MD, Barrueco ÁS, Martinez-Beneyto Y, et al. Clinical evaluation of antiseptic mouth rinses to reduce salivary load of SARS-CoV-2. Sci Rep. 2021 Dec 22;11(1):24392.
   PubMed Web of Science ®Google Scholar
• La Scola B, Le Bideau M, Andreani J, et al. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur J Clin Microbiol Infect Dis. 2020;39(6):1059–1061.
   PubMed Web of Science ®Google Scholar
• Pelletier JS, Tessema B, Frank S, et al. Efficacy of povidone-iodine nasal and oral antiseptic preparations against severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). Ear Nose Throat J. 2021;100(2_suppl):192S–196S.
   PubMed Web of Science ®Google Scholar
• To KK, Tsang OT, Leung WS, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20(5):565–574.
   PubMed Web of Science ®Google Scholar
• Deana NF, Seiffert A, Aravena-Rivas Y, et al. Recommendations for safe dental care: A Systematic review of clinical practice guidelines in the first year of the COVID-19 pandemic. Int J Environ Res Public Health. 2021 Sep 24;18(19):10059.
   PubMed Web of Science ®Google Scholar
• Kariwa H, Fujii N, Takashima I. Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents. Dermatology. 2006;212(Suppl 1):119–123.
   PubMed Web of Science ®Google Scholar
• Meyers C, Robison R, Milici J, et al. Lowering the transmission and spread of human coronavirus. J Med Virol. 2021;93(3):1605–1612.
   PubMed Web of Science ®Google Scholar
• Steinhauer K, Meister TL, Todt D, et al. Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European standard EN 14476. J Hosp Infect. 2021;111:180–183.
   PubMed Web of Science ®Google Scholar
• Sreebny LM. Saliva in health and disease: an appraisal and update. Int Dent J. 2000;50(3):140–161.
   PubMed Web of Science ®Google Scholar
• Schurmann M, Aljubeh M, Tiemann C, et al. Mouthrinses against SARS-CoV-2: anti-inflammatory effectivity and a clinical pilot study. Eur Arch Otorhinolaryngol. 2021;278(12):5059–5067.
   PubMed Web of Science ®Google Scholar
• Huang YH, Huang JT. Use of chlorhexidine to eradicate oropharyngeal SARS-CoV-2 in COVID-19 patients. J Med Virol. 2021;93(7):4370–4373.
   PubMed Web of Science ®Google Scholar
• Costa DD, Brites C, Vaz SN, et al. Chlorhexidine mouthwash reduces the salivary viral load of SARS-CoV-2: A randomized clinical trial. Oral Dis. 2021 Nov 26. DOI:10.1111/odi.14086
   Web of Science ®Google Scholar
• Eduardo FP, Corrêa L, Heller D, et al. Salivary SARS-CoV-2 load reduction with mouthwash use: A randomized pilot clinical trial. Heliyon. 2021 Jun;7(6):e07346.
   PubMed Web of Science ®Google Scholar
• Elzein R, Abdel-Sater F, Fakhreddine S, et al. In vivo evaluation of the virucidal efficacy of chlorhexidine and povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial. J Evid Based Dent Pract. 2021 Sep;21(3):101584.
   PubMed Web of Science ®Google Scholar
• Peng X, Xu X, Li Y, et al. Transmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci. 2020 Mar 3;12(1):9.
   Web of Science ®Google Scholar
• Kowalski LP, Sanabria A, Ridge JA, et al. COVID-19 pandemic: effects and evidence-based recommendations for otolaryngology and head and neck surgery practice. Head Neck. 2020;42(6):1259–1267.
   PubMed Web of Science ®Google Scholar
• Mendoza JPI M, Ubillus BP T, Bolivar GT S, et al. Antiviral effect of mouthwashes against SARS-COV-2: A systematic review. Saudi Dent J. 2022;34(3):167–193.
   PubMed Web of Science ®Google Scholar
• Schutz D, Conzelmann C, Fois G, et al. Carrageenan-containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures. Am J Physiol Lung Cell Mol Physiol. 2021;320(5):L750–L7L6.
   PubMed Web of Science ®Google Scholar
• R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2020.
   Google Scholar